SYRS: Syros Pharmaceuticals, Inc. Company Aggregate Debts

Corporate company logo of Syros Pharmaceuticals, Inc. (SYRS)

Syros Pharmaceuticals (SYRS) laboratories consistently develop oncology drugs, utilizing partner capacities without technical failures. The business relies on environmental standards, implementing energy saving and emission filtration within gene therapy centers. This daily price chart reflects a level of 0.00, confirming a critical funding shortage following clinical failures, despite the transparency of the restructuring and the scientific expertise of top management.

Syros Pharmaceuticals, Inc. (SYRS): Company Total Debt from 07/04/2022 to 03/29/2025

Metric breakdowns and analytics for Syros Pharmaceuticals, Inc. (SYRS)

- stock price and consensus target price:
Share Price Syros Pharmaceuticals, Inc|SYRS - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Syros|SYRS - Total Company Value
- balance sheet equity data:
Net Assets per Share Syros Pharmaceuticals|SYRS - Company Net Assets|Market-to-Book Ratio syros.com|SYRS - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Syros Pharmaceuticals|SYRS - Long-Term Debt to Equity|Current Liabilities to Capital Syros Pharmaceuticals Inc.|SYRS - Company Debts|Debts to Net Assets Syros|SYRS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Syros Pharmaceuticals
Fundamental company analysis:SYRS, Syros Pharmaceuticals, Inc
Finished products of Syros Pharmaceuticals

Total debt measures the company's aggregate liabilities, determining the interest burden and the risk of margin erosion during a period of expensive borrowing. By analyzing the debt history, an investor assesses the financial stability of Syros Pharmaceuticals (SYRS), which is currently critical for restructuring its R&D strategy following a decline in patent protection effectiveness and failed clinical trials.

Who Syros Pharmaceuticals competes with

Tempus AI, Inc. - Company Aggregate Debt|Company Aggregate Debts QGEN (Qiagen N.V.)|Company Aggregate Debts ionispharma.com IONS|RGEN - Company Debts|Company Total Debt Obligations Avidity Biosciences Inc RNA|CRSP (CRISPR Therapeutics Corp) - Company Total Debt|Company Cumulative Debt GeneDx Corp (WGS)|Company Debts Ultragenyx Pharmaceutical|BEAM: Aggregate Debt Obligations|Company Debts Sarepta (SRPT)|TWST - Company Cumulative Debt|Company Debts 10x Genomics Corp TXG|Company Total Debt Obligations Intellia Corp (NTLA)|STOK: Company Total Debt|Aggregate Debt Obligations BLFS (biolifesolutions.com)|Wave Life Sciences Ltd. (WVE) - Company Debts|Company Aggregate Indebtedness MAZE (Maze Therapeutics, Inc.)|SION (Sionna Pharma) - Company Aggregate Debts|PRME: Aggregate Debt Obligations|Company Aggregate Debts TSHA|Company Aggregate Debts uniqure.com (QURE)|Company Debts MeiraGTx MGTX|Aggregate Debt Obligations RGNX|SLDB - Company Debts|Ocugen Pharma (OCGN) - Company Total Debt|PACB: Company Aggregate Debts|benitec.com (BNTC) - Company Aggregate Debts|DSGN (Design Therapeutics, Inc.) - Company Aggregate Debts|Company Total Debt Rocket Pharma (RCKT)|Company Aggregate Debts FDMT|LXEO - Company Cumulative Debt|Korro Bio - Company Total Debt|Company Aggregate Debts editasmedicine.com EDIT|SLN: Company Total Debt|ProQR Therapeutics N.V. - Company Cumulative Indebtedness|CDXS: Company Aggregate Debts|SGMO - Company Total Debt Obligations|NAUT (Nautilus Biotechnology, Inc.) - Company Aggregate Debts|Company Total Debt metagenomi.co (MGX)|Company Aggregate Debts DTIL|Company Aggregate Debts generationbio.com (GBIO)|Company Debts Boundless Bio, Inc BOLD|Exicure Inc. - Company Debts|IMNN - Company Debts|Company Total Debt Obligations Phio Pharmaceuticals PHIO|mustangbio.com (MBIO) - Company Debts|RNAZ - Company Total Debt Obligations|Company Total Debt BNGO|Company Cumulative Debt Applied DNA Corp APDN|Company Debts bluebird bio, Inc. (BLUE)|IPA (immunoprecise.com) - Aggregate Debt Obligations|Company Debts Omega Therapeutics, Inc. OMGA|Company Total Debt Obligations Singular Genomics Systems, Inc. (OMIC)|Regulus Therapeutics Inc - Company Aggregate Debts|TBIO (Telesis Bio, Inc) - Company Aggregate Debt|TRACON Pharmaceuticals (TCON) - Company Debts|Company Aggregate Debt UBX